您当前的位置：
首页 >
文章列表页 >
Effect of Tongxinluo on H9c2 Cardiomyocytes Hypertrophy and Expression of Connexin43 mRNA Induced by Isoproterenol
更新时间：2024-01-04

    • Effect of Tongxinluo on H9c2 Cardiomyocytes Hypertrophy and Expression of Connexin43 mRNA Induced by Isoproterenol

    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 18, Issue 23, Pages: 191-194(2012)

    • Published：2012

    移动端阅览

  • YANG Jun, DING Sai-liang, DENG Biao, et al. Effect of Tongxinluo on H9c2 Cardiomyocytes Hypertrophy and Expression of Connexin43 mRNA Induced by Isoproterenol[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(23): 191-194. DOI：

  •  
  •  

0

Views

6

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Establishment and Evaluation of Mouse Model of Ischemic Heart Disease with Qi and Yin Deficiency Syndrome Based on Proteomics
Mechanism of Aconiti Kusnezoffii Radix Processed with Chebulae Fructus Against H9c2 Cardiomyocyte Toxicity Based on TRPV1 Channel
Collaterals Doctrine Guided Investigation into Traditional Chinese Medicine Pathogenesis and Clinical Treatment of Myocardial Fibrosis Following Acute Myocardial Infarction
Analysis of Pathogenesis and Treatment of Chronic Coronary Syndrome Based on Vessel-collateral Theory
Effect of Picroside Ⅱ on Expression of microRNA-1 in H2O2-induced H9c2 Cardiomyocytes Damage

Related Author

ZHANG Qiuyan
LI Ying
GAO Yunxiao
HU Longxiao
YUAN Yue
CHEN Xiaoxiao
SHI Yali
REN Junguo

Related Institution

Beijing University of Chinese Medicine
Beijing Key Laboratory of Chinese Materia Pharmacology，Institute of Basic Medical Sciences， Xiyuan Hospital，China Academy of Chinese Medical Sciences
Natural History Museum of China
School of Graduate，Hebei University of Chinese Medicine
Key Disciplines of Cardio-cerebral Vessel Collateral Disease， National Administration of Traditional Chinese Medicine（TCM）， State Key Laboratory of Collateral Disease Research and Innovative of TCM， Hebei Yiling Pharmaceutical Research Institute
0